Surgical vacuum-assisted closure for treatment of vinorelbine extravasation  by Lucchina, Stefano & Fusetti, Cesare
Chinese Journal of Traumatology 2009; 12(4):247-249 . 247 .
DOI: 10.3760/cma.j.issn.1008-1275.2009.04.012
Surgical Department,  Locarno’s Regional Hospital,
Via all’Ospedale 1 6600 Locarno, Switzerland (Lucchina S
and Fusetti C)
*Corresponding author: E-mail: stefano.lucchina
@handregistry.com
Surgical vacuum-assisted closure for treatment of
vinorelbine extravasation
Stefano Lucchina*  and  Cesare Fusetti
Skin necrosis from inadvertent extravasation in sur-
rounding soft tissues is a rare but not uncommon com-
plication of Vinorelbine tartrate, a cytotoxic chemothera-
peutic drug widely used intravenously in the treatment
of malignant diseases.1,2
The treatment of chemotherapeutic extravasation
injuries is represented by prompt removal of the fluid
from the subcutaneous perivenous space with hyalu-
ronidase infiltration and multiple skin punctures around
the area of extravasation, saline lavage and liposuction
where appropriate,3 topical dimethyl sulfoxide (DMSO),4
surgical debridement and flaps or skin grafts.5 Vacuum-
assisted closure (VAC) dressing is a well-known therapy
for the management of patients with soft tissue injuries.6
This report described our experience with VAC as an
alternative therapy for skin lesions induced by vinorelbine
extravasation.
CASE REPORT
A 74-year-old male was admitted into our institution
with a lung metastatic squamocellular carcinoma and
treated with Vinorelbine (Navelbine, Burroughs
Wellcome Company, Research Triangle Park, North
Carolina, USA). Two cycles of the drug had been given
intravenously in the dorsum of the right hand. He was
referred to us two days after extravasation of the drug.
The results of routine blood tests were listed as follows:
2.1x109 white cells /L,  haemoglobin 7.2 g/dl, C-reactive
protein 67 mg/L.
He complained of pain, erythema, swelling and blis-
ters (Fig.1A). Radical surgical debridement of the in-
jured tissue was done (Fig.1B) and a modified VAC
dressing with a continuous negative pressure of 125
mm Hg was applied for 1 week (Fig.1C). At that time,
the wound showed an improvement of redness and
swelling with granulation tissue growing from the deep
layers. No further extension of the necrotic process (2
cm×3 cm) was detectable in the extensor tendons and
the skin all around (Fig. 2A). Wound closure was
achieved by immediate split-thickness skin graft asso-
ciated with a rotation-advancement flap (Fig. 2B). Then
the blood tests revealed an improvement of previous pa-
rameters (8.0×109 white cells /L,  haemoglobin 10.4 g/dl,
C-reactive protein 27 mg/L) and the patient was promptly
discharged. The follow-ups at 4 and 6 weeks after sur-
gery revealed a satisfactory appearance of the dorsum
of the hand with complete “restitution ad integration”
either aesthetically or functionally (Fig. 2C).
DISCUSSION
Vinorelbine is a semisynthetic analogue of vinblas-
tine  working as an antineoplastic agent, being an in-
hibitor of microtubule assembly, approved for the first-
line treatment of patients with advanced non-small-cell
lung cancer in many countries.2  Among the intravenous
drugs, vinorelbine and doxorubicin have the highest
destructive power. Their intravenous infiltration can re-
sult in skin necrosis, so they have the worst potential
complication.1 The drug infiltrates the dermal layer, pro-
ducing a separation of the dermis from necrotic
epidermis, associated with cytologic atypia and focal
necrosis of eccrine glands.1  The degree of subcutane-
ous extravasation is often underestimated.
The dorsum of the hand with the extensor tendons
and the palmar aspect of the wrist with the flexor
tendons, nerves, major arteries are the areas with se-
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vere morbidity during extravasation. Clinical signs of
chemotherapeutic extravasation include pain, erythema,
swelling, oedema, and features of reflex sympathetic
dystrophy.5 Early management of skin lesions has been
The  treatments of chemotherapeutic extravasation
injuries in the literature are represented by prompt re-
moval of the fluid from the subcutaneous perivenous
space with hyaluronidase infiltration and multiple skin
punctures around the area of extravasation, saline lav-
age and liposuction where appropriate,3 topical DMSO,4
surgical debridement and flaps or skin grafts.5 Only one
report is specifically addressed to the treatment of
vinorelbine-induced skin lesions in humans. 2 The above-
mentioned techniques are not always satisfactory, par-
ticularly after the extravasation of large amounts of very
damaging cytotoxic agents in immunocompromised
patients with prolonged treatments and poor function. 8
Therefore, the ideal treatment has to be fast and
effective in removing the fluids, accessible, less invasive,
simple in application and suitable for out-patients and
without complications. It should stop chronic progres-
sion of subcutaneous, peritendinous and cutaneous pro-
gression of necrosis due to vinorelbine because it can-
strongly recommended 2,7 to stop expansion of the dam-
aged area and prevent severe injuries like large open
wounds with chronic progression, which  rarely heal
spontaneously and can produce significant disability.3
not be locally metabolized or removed from the area of
lymphatic circulation.9
For this purpose after radical debridement, a VAC
dressing, which can meet all the above requirements,
was applied for 1 week to treat the patient with vinorelbine
extravasation. Previous clinical and experimental stud-
ies have demonstrated an improved circulation, a re-
duction of oedema and cell proliferation in wounds
treated by VAC.10,11 Circulation is improved by the in-
crease of capillary calibre and blood volume and the
stimulation of angiogenesis. Reduced permeability of
blood vessels and decrease of wound oedema are
achieved by narrowing endothelial spaces and by the
restoration of capillary basement membranes.10 Espe-
cially for the immunocompromised patients, who are
not prone to invasive and long procedures,  VAC therapy
has been proved to be easily accessible and simple in
application and can be defined as a safe and effective
adjuvant therapy for the management of skin necrosis
Fig. 1. Dorsum of the right hand after vinorelbine extravasation. A: Redness and blisters are evident in the site of extravasation;
B:Immediate radical surgical debridement; C: Modif ied VAC dressing.
Fig. 2. A: Dorsum of the right hand with improved redness and granulating tissue growing from the deep layers of the wound one week
after VAC treatment; B:Wound closure achieved by immediate split-thickness skin graft associated with a rotation-advancement flap;
C: Clinical picture of the hand 6 weeks after treatment.
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from chemotherapeutic agents.
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